152 related articles for article (PubMed ID: 38126436)
1. Brazilian national production of active pharmaceutical ingredients: regulatory and strategic framework.
Tonini MDL; Lopes RO; Barbosa MLC
An Acad Bras Cienc; 2023; 95(suppl 2):e20230321. PubMed ID: 38126436
[TBL] [Abstract][Full Text] [Related]
2. Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey.
Fortunak JM; de Souza RO; Kulkarni AA; King CL; Ellison T; Miranda LS
Antivir Ther; 2014; 19 Suppl 3(0 3):15-29. PubMed ID: 25310430
[TBL] [Abstract][Full Text] [Related]
3. The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices.
Petrelli F; Caraffa A; Scuri S; Grappasonni I; Magrini E; Cocchini A
Acta Biomed; 2019 May; 90(2):288-299. PubMed ID: 31125009
[TBL] [Abstract][Full Text] [Related]
4. Designing greener active pharmaceutical ingredients: Insights from pharmaceutical industry into drug discovery and development.
Puhlmann N; Vidaurre R; Kümmerer K
Eur J Pharm Sci; 2024 Jan; 192():106614. PubMed ID: 37858896
[TBL] [Abstract][Full Text] [Related]
5. Estimating The Effects Of COVID-19 On Globalized Markets For Active Pharmaceutical Ingredients.
Barber M; Ramachandran R; Moon S
Health Aff (Millwood); 2024 Jul; 43(7):959-969. PubMed ID: 38950300
[TBL] [Abstract][Full Text] [Related]
6. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
Nunn AS; Fonseca EM; Bastos FI; Gruskin S; Salomon JA
PLoS Med; 2007 Nov; 4(11):e305. PubMed ID: 18001145
[TBL] [Abstract][Full Text] [Related]
7.
Paranhos J; Hasenclever L; Perin FS
J Law Med Ethics; 2023; 51(S1):126-135. PubMed ID: 38156350
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies.
Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC
Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068
[TBL] [Abstract][Full Text] [Related]
9. Global Production of Active Pharmaceutical Ingredients for US Generic Drugs Experiencing Shortages.
Socal MP; Crane MA; Anderson GF
JAMA; 2024 May; 331(20):1763-1765. PubMed ID: 38683587
[TBL] [Abstract][Full Text] [Related]
10. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
11. Can Brazil play a more important role in global tuberculosis drug production? An assessment of current capacity and challenges.
Gemal A; Keravec J; Menezes A; Trajman A
BMC Public Health; 2013 Mar; 13():279. PubMed ID: 23537151
[TBL] [Abstract][Full Text] [Related]
12. Expanding drug access in Brazil: lessons for Latin America and Canada.
Cohen JC
Can J Public Health; 2006; 97(6):I15-8. PubMed ID: 17203728
[TBL] [Abstract][Full Text] [Related]
13. Building the Momentum for A Stronger Pharmaceutical System in Africa.
Ussai S; Chillotti C; Stochino E; Deidda A; Ambu G; Anania L; Boccalini A; Colombo F; Ferrari A; Pala D; Puddu E; Rapallo G; Pistis M
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328999
[TBL] [Abstract][Full Text] [Related]
14. Competition And Vulnerabilities In The Global Supply Chain For US Generic Active Pharmaceutical Ingredients.
Socal MP; Ahn K; Greene JA; Anderson GF
Health Aff (Millwood); 2023 Mar; 42(3):407-415. PubMed ID: 36791331
[TBL] [Abstract][Full Text] [Related]
15. Combining Isolation-Free and Co-Processing Manufacturing Approaches to Access Room Temperature Ionic Liquid Forms of APIs.
Stocker MW; Tsolaki E; Harding MJ; Healy AM; Ferguson S
J Pharm Sci; 2023 Aug; 112(8):2079-2086. PubMed ID: 36806585
[TBL] [Abstract][Full Text] [Related]
16. Comparison of permitted daily exposure (PDE) values for active pharmaceutical ingredients (APIs) - Evidence of a robust approach.
Sehner C; Bernier T; Blum K; Clemann N; Glogovac M; Hawkins WA; Kohan M; Linker F; Lovsin-Barle E; Osadolor O; Pfister T; Schulze E; Schwind M; Tuschl G; Wiesner L
Regul Toxicol Pharmacol; 2024 Jun; 150():105649. PubMed ID: 38782234
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021.
Wande DP; Sangeda RZ; Tibalinda P; Mutta IK; Mkumbwa S; Bitegeko A; Kaale E
PLoS One; 2019; 14(8):e0220701. PubMed ID: 31404109
[TBL] [Abstract][Full Text] [Related]
18. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
19. Process Analytical Technology for Crystallization of Active Pharmaceutical Ingredients.
Malwade CR; Qu H
Curr Pharm Des; 2018; 24(21):2456-2472. PubMed ID: 29956616
[TBL] [Abstract][Full Text] [Related]
20. Microencapsulation for Pharmaceutical Applications: A Review.
Yan C; Kim SR
ACS Appl Bio Mater; 2024 Feb; 7(2):692-710. PubMed ID: 38320297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
